June 4, 2026 New Research from Merck Animal Health Reveals Hidden Parasitic Infections Cost Global Dairy Industry Billions Each Year May 4, 2026 In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to Help Advance Veterinary Wellbeing March 18, 2026 FDA Approves BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs February 25, 2026 FDA Approves NUMELVI (atinvicitinib tablets) for Dogs from Merck Animal Health The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis February 24, 2026 Merck Animal Health Wins 2025 S&P Global Award in Best Product and Best Product Companion Animal Food Animal Categories for NUMELVI and INNOVAX ND-IBD-ILT, Respectively December 4, 2025 FDA Conditionally Approves Merck Animal Healths EXZOLT CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis) November 4, 2025 Mexicos SADER Approves Merck Animal Healths EXZOLT 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis) October 23, 2025 New Data from Merck Animal Health Demonstrates that Intranasal Vaccination Against Bovine Coronavirus with BOVILIS NASALGEN-C (Lyophilisate and Solvent for Suspension for Cattle) Significantly Improves Production in Veal Calves
We recognize that effectiveness can vary from person to person, and we carefully monitor potential side effects to ensure your safety
Business Type Exporter, Manufacturer, Supplier Payment Mode Telegraphic Transfer (T/T) Certification ISO9001:2015 Related Products Explore Related Categories More Products From This Seller Seller Details Office 2316, Yuanang building, No
com forward slash Dr
